Mobile Coaching to Improve HPV Vaccine Delivery
Evaluating the Feasibility of a Mobile Coaching Intervention to Improve HPV Vaccine Delivery
2 other identifiers
interventional
21
1 country
1
Brief Summary
The purpose of this study is to examine the feasibility of using Checkup Coach, a mobile coaching intervention, to improve the way that primary care providers recommend HPV vaccination to adolescent patients and their parents. To conduct this feasibility study, the investigators will deliver the Checkup Coach intervention to 20 Kaiser Permanente Washington primary care providers who routinely recommend HPV vaccine to adolescent patients. The investigators will use a single-arm, pre-post design. Participating primary care providers will attend a 1-hour virtual communication workshop and then use a mobile phone app to receive additional coaching for 12 weeks. Providers will complete surveys at three time points: before the communication workshop, immediately after the workshop, and at 12-week follow-up. Surveys will assess changes in providers' self-reported HPV vaccine recommendation practices and beliefs about HPV vaccine and also acceptability of the intervention. The investigators hypothesizes that providers' HPV vaccine communication will improve between baseline and 12-week follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 21, 2021
CompletedFirst Submitted
Initial submission to the registry
October 21, 2021
CompletedFirst Posted
Study publicly available on registry
November 3, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 14, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 14, 2022
CompletedResults Posted
Study results publicly available
July 25, 2022
CompletedJuly 25, 2022
July 1, 2022
7 months
October 21, 2021
May 31, 2022
July 20, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Change in HPV Vaccine Recommendation Quality Score
The change in providers' mean composite score on a 5-item index of self-reported use of HPV vaccine communication practices with scores ranging from 5-25 (5 indicating the lowest quality score to 25 indicating the highest quality score).
Baseline, 12 weeks
Study Arms (1)
Primary care providers
EXPERIMENTALProviders who treat 11-12 year old adolescent patients in participating Kaiser Permanente Washington pediatric and family medicine practices.
Interventions
The intervention consists of two main components: a webinar communication workshop and use of the Checkup Coach mobile app. The Checkup Coach intervention begins with a brief (\<1 hour), communication training workshop that reviews evidence on HPV vaccination, models guideline-consistent recommendations, trains providers to address parent concerns, and facilitates discussion of shared goals for improving. Next, providers are invited to download and use the Checkup coach mobile app at their discretion for the 12-week study period. Providers complete in-app self-assessments and receive tailored feedback about their HPV vaccine recommendation quality, progress toward improving recommendation practices, a dashboard of aggregate HPV vaccination coverage for patients in their clinic, and tips for addressing parents' concerns about HPV vaccination every time they use the app.
Eligibility Criteria
You may qualify if:
- Primary care providers who treat 11-12 year old adolescent patients in participating Kaiser Permanente Washington pediatric and family medicine practices
You may not qualify if:
- Primary care providers who do not treat adolescent patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- UNC Lineberger Comprehensive Cancer Centerlead
- Kaiser Permanentecollaborator
- University of Minnesotacollaborator
- National Cancer Institute (NCI)collaborator
Study Sites (1)
Kaiser Permanente Washington Health Research Institute
Seattle, Washington, 98101, United States
Results Point of Contact
- Title
- Melissa Gilkey, PhD
- Organization
- University of North Carolina at Chapel Hill
Study Officials
- PRINCIPAL INVESTIGATOR
Melissa B Gilkey, PhD
University of North Carolina
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 21, 2021
First Posted
November 3, 2021
Study Start
June 21, 2021
Primary Completion
January 14, 2022
Study Completion
January 14, 2022
Last Updated
July 25, 2022
Results First Posted
July 25, 2022
Record last verified: 2022-07
Data Sharing
- IPD Sharing
- Will not share